nancy lynn snyderman MD - Jun 29, 2024 Form 4 Insider Report for Alkermes plc. (ALKS)

Role
Director
Signature
/s/ Shantale Greenson, attorney-in-fact for Nancy Snyderman
Stock symbol
ALKS
Transactions as of
Jun 29, 2024
Transactions value $
-$35,307
Form type
4
Date filed
7/1/2024, 05:01 PM
Previous filing
Jun 14, 2024
Next filing
Nov 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALKS Ordinary Shares Options Exercise +6.1K 6.1K Jun 29, 2024 Direct F3
transaction ALKS Ordinary Shares Tax liability -$35.3K -1.47K -24% $24.10 4.64K Jun 29, 2024 Direct
holding ALKS Ordinary Shares 20.8K Jun 29, 2024 By the Snyderman Trust F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALKS Restricted Stock Unit Award Options Exercise -6.1K -100% 0 Jun 29, 2024 Ordinary Shares 6.1K Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 427 shares purchased on March 4, 2022 and 20,356 shares transferred by the reporting person on September 6, 2023.
F2 Shares are held by the Nancy Lynn Snyderman Revocable Trust (the "Snyderman Trust"), of which the reporting person is both the sole trustee and sole beneficiary.
F3 Each restricted stock unit represents a contingent right to receive one ordinary share.
F4 This award is fully vested in accordance with its terms.